世界のバイオ医薬品添加剤市場2021-2028:製品別(ポリオール、可溶化剤・界面活性剤/乳化剤、炭水化物)、地域別

◆英語タイトル:Biopharmaceutical Excipients Market Size, Share & Trends Analysis Report By Product (Polyols, Solubilizers & Surfactants/Emulsifiers, Carbohydrates), By Region, And Segment Forecasts, 2021 - 2028
◆商品コード:GV21MA028
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2021年2月26日
◆ページ数:150
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥678,300見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥792,300見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,020,300見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

グランドビューリサーチ社は、世界のバイオ医薬品添加剤市場規模が2028年までに34億ドルに達すると予測しています。2021年から2028年までに年平均6.5%成長する見通しです。本調査レポートでは、バイオ医薬品添加剤の世界市場について広く調査・分析し、エグゼクティブサマリー、調査手法・範囲、市場変動・動向・範囲、製品別(可溶化剤・界面活性剤/乳化剤、ポリオール、炭水化物、特殊賦形剤)分析、地域別分析、競争状況など、以下の構成でまとめております。
・エグゼクティブサマリー
・調査手法・範囲
・市場変動・動向・範囲
・バイオ医薬品添加剤の世界市場規模:製品別(可溶化剤・界面活性剤/乳化剤、ポリオール、炭水化物、特殊賦形剤)
・バイオ医薬品添加剤の世界市場規模:地域別
・競争状況
【レポートの概要】

Biopharmaceutical Excipients Market Growth & Trends

The global biopharmaceutical excipients market size is expected to reach USD 3.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.5% from 2021 to 2028. The factors driving the market growth include increasing development of biosimilars, instability associated with drugs & vaccines, and growing focus on the development of novel drugs, among others.

The changing regulatory scenarios by both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have impacted drug development. Several legislative proposals are addressing new ways for lowering the cost of prescription drugs. Similarly, in recent years there is an increasing focus on drug-manufacturing quality has led to several recalls by FDA and the EMA. Hence, the stringent investigations related to an examination of drugs are likely to promote the use of specific excipients for developing efficient drugs.

In addition, companies are collaborating with government authorities for increasing the application of novel compounds. For instance, in December 2019, U.S. FDA started a pilot program to evaluate novel biopharmaceutical excipients. Later, the initiative was supported by several companies such as AstraZeneca, Regeneron, and Janssen for FDA’s plan to review novel biopharmaceutical excipients. Regeneron highlighted different novel compounds that can potentially help in improving public health for example hydrophobic salts can reduce the viscosity of highly concentrated antibody formulations.

Moreover, the rising focus on the rapid development of COVID-19 vaccines and therapeutic drugs is further driving the market growth. Excipients have an essential role in the development of biologics as it helps in stabilizing the drug during storage and processing. The use of appropriate biopharmaceutical excipients enables the development of novel therapies and robust pharmaceutical products for fighting against the pandemic.

Large-scale pharmaceutical companies signed a long-term supply agreement with companies for supporting the development of COVID-19 vaccines. For instance, in November 2020, Pfizer Inc. signed a five-year contract with Croda International for lipid-based excipients that will be used for manufacturing Pfizer’s COVID-19 vaccine candidate. Similarly, in May 2020, Moderna signed a supply agreement with CordenPharma for the large-scale production of lipid excipient for the development of mRNA-1273, Moderna’s COVID-19 vaccine candidate.

Biopharmaceutical Excipients Market Report Highlights

• Carbohydrates accounted for the largest revenue share of 36.2% in 2020 owing to the increasing use of carbohydrates owing to their several advantages

• The advantages include it helps the efficient binding of tablet ingredients, enables accurate dosing and protecting the tablet from harsh environmental conditions, among others

• Sucrose amongst the carbohydrates dominated with a market share of 32.8% owing to its increasing application in stabilizing proteins

• Starch is expected to witness the fastest CAGR of 6.6% from 2021 to 2028 owing to the increasing launch of new starch excipients

• For instance, in May 2019, Colorcon Inc. launched STARTAB, a new starch tableting excipient. It is developed by directly compressible starch for enhancing the stability of moisture sensitive API

• North America has emerged as the highest revenue-generating region, representing a market share of 32.0% in 2020

• Large pharmaceutical companies are entering in collaboration with the companies in the region which can be attributed to market growth

• For instance, in February 2020, MilliporeSigma entered in an agreement with ReForm Biologics LLC for commercializing ReForm’s excipients that are used in biotherapeutic formulations

• In Asia Pacific, the market is expected to witness a lucrative CAGR of 7.0% from 2021 to 2028 owing to the increasing production of biosimilar drugs in the region

• The government in this region is promoting biosimilar development. For instance, the government of South Korea provided regulatory guidance to local biosimilars companies for aiming to develop around 22.0% of global biosimilars by 2020

【レポートの目次】

Table of Contents

Chapter 1 Executive Summary
1.1 Market Snapshot
Chapter 2 Methodology and Scope
2.1 Market Segmentation & Scope
2.1.1Estimates and Forecast Timeline
2.2 Research Methodology
2.3 Information Procurement
2.3.1 Purchased database:
2.3.2 GVR’s internal database
2.3.3 Secondary sources:
2.3.4 Primary Research:
2.3.5 Details of Primary Research
2.3.5.1 Data for primary interviews in North America
2.3.5.2 Data for primary interviews in Europe
2.3.5.3 Data for primary interviews in Asia Pacific
2.3.5.4 Data for primary interviews in Latin America
2.3.5.5 Data for primary interviews in Middle East & Africa
2.4 Information or Data Analysis
2.4.1Data Analysis Models
2.5 Market Formulation & Validation
2.6 Model Details
2.6.1Commodity Flow Analysis (Model 1)
2.6.1.1 Approach 1: Commodity Flow Approach
2.6.2Volume Price Analysis (Model 2)
2.6.2.1 Approach 2: Volume Price Analysis
2.7 List of Secondary Sources
2.8 List of Primary Sources
2.9 Objectives
2.9.1 Objective 1:
2.9.2 Objective 2:
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Chemical and physical instability of biopharmaceuticals is boosting the development of excipients
3.1.1.2 Increase in focus of pharmaceutical players on bio generic market
3.1.1.3 Cost-efficiency and competency of manufacturers
3.1.1.4 Patent expiry of biological actives
3.1.1.5 Rising adoption of multifunctional excipients
3.1.2 Market restraint analysis
3.1.2.1 Challenges in development of excipients for biologics
3.1.2.2 Issues pertaining to supply chain in biopharmaceutical industry
3.2 Penetration & Growth Prospect Mapping for Products, 2020
3.3 Biopharma Excipients Market-SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis – Porter’s
3.5 Biopharmaceutical Excipients Market: COVID-19 Impact Analysis
Chapter 4 Market Categorization: Product Estimates & Trend Analysis
4.1 Biopharmaceutical Excipients Market: Product Movement Analysis, 2020 & 2028
4.2 Solubilizers & Surfactants/Emulsifiers
4.2.1 Global solubilizers & surfactants/emulsifiers market, by revenue 2017 – 2028(USD Million)
4.2.2 Global solubilizers & surfactants/emulsifiers market, by volume 2017 – 2028 (Tonnes)
4.2.3 Triglycerides
4.2.3.1 Global triglycerides market, by revenue 2017 – 2028 (USD Million)
4.2.3.2 Global triglycerides market, by volume 2017 – 2028 (Tonnes)
4.2.4 Esters
4.2.4.1 Global esters market, by revenue 2017 – 2028 (USD Million)
4.2.4.2 Global esters market, by volume by 2017 – 2028 (Tonnes)
4.2.5 Other solubilizers
4.2.5.1 Global other solubilizers market, by revenue 2017 – 2028 (USD Million)
4.2.5.2 Global other solubilizers market, by volume 2017 – 2028 (Tonnes)
4.3 Polyols
4.3.1 Global polyols market, by revenue 2017 – 2028 (USD Million)
4.3.2 Global polyols market, by volume 2017 – 2028 (Tonnes)
4.3.3 Mannitol
4.3.3.1 Global mannitol market, by revenue 2017 – 2028 (USD Million)
4.3.3.2 Global mannitol market, by volume 2017 – 2028 (Tonnes)
4.3.4 Sorbitol
4.3.4.1 Global sorbitol market, by revenue 2017 – 2028 (USD Million)
4.3.4.2 Global sorbitol market, by volume 2017 – 2028 (Tonnes)
4.3.5 Other polyols
4.3.5.1 Global other polyols market, by revenue 2017 – 2028 (USD Million)
4.3.5.2 Global other polyols market, by volume 2017 – 2028 (Tonnes)
4.4 Carbohydrates
4.4.1 Global carbohydrates market, by revenue 2017 – 2028 (USD Million)
4.4.2 Global carbohydrates market, by volume 2017 – 2028 (Tonnes)
4.4.3 Dextrose
4.4.3.1 Global dextrose market, by revenue 2017 – 2028 (USD Million)
4.4.3.2 Global dextrose market, by volume 2017 – 2028 (Tonnes)
4.4.4 Sucrose
4.4.4.1 Global sucrose market, by revenue 2017 – 2028 (USD Million)
4.4.4.2 Global sucrose market, by volume 2017 – 2028 (Tonnes)
4.4.5 Starch
4.4.5.1 Global starch market, by revenue 2017 – 2028 (USD Million)
4.4.5.2 Global starch market, by volume 2017 – 2028 (Tonnes)
4.4.6 Other carbohydrate excipients
4.4.6.1 Global other carbohydrates market, by revenue 2017 – 2028 (USD Million)
4.4.6.2 Global other carbohydrates market, by volume 2017 – 2028 (Tonnes)
4.5 Specialty Excipients
4.5.1 Global specialty excipients/others market, by revenue 2017 – 2028 (USD Million)
4.5.2 Global specialty excipients/others market, by volume 2017 – 2028 (Tonnes)
Chapter 5 Market Categorization: Regional Estimates & Trend Analysis, by Product
5.1 Biopharmaceutical Excipients Market Share By Region, 2020 & 2028
5.2 North America
5.2.1 North America biopharmaceutical excipients market, 2017 – 2028 (USD Million)
5.2.2 U.S.
5.2.2.1U.S. biopharmaceutical excipients market, 2017 – 2028 (USD Million)
5.2.3 Canada
5.2.3.1 Canada biopharmaceutical excipients market, 2017 – 2028 (USD Million)
5.3 Europe
5.3.1 Europe biopharmaceutical excipients market, 2017 – 2028 (USD Million)
5.3.2 Germany
5.3.2.1 Germany biopharmaceutical excipients market, 2017 – 2028 (USD Million)
5.3.3 U.K.
5.3.3.1 U.K. biopharmaceutical excipients market, 2017 – 2028 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific biopharma excipients market, by revenue 2017 – 2028 (USD Million)
5.4.2 Japan
5.4.2.1 Japan biopharma excipients market, by revenue 2017 – 2028 (USD Million)
5.4.3 China
5.4.3.1 China biopharma excipients market, by revenue 2017 – 2028 (USD Million)
5.4.4 India
5.4.4.1 India biopharma excipients market, by revenue 2017 – 2028 (USD Million)
5.4.5 Malaysia
5.4.5.1 Malaysia biopharma excipients market, by revenue 2017 – 2028 (USD Million)
5.4.6 South Korea
5.4.6.1 South Korea biopharma excipients market, by revenue 2017 – 2028 (USD Million)
5.4.7 Philippines
5.4.7.1 Philippines biopharma excipients market, by revenue 2017 – 2028 (USD Million)
5.4.8 New Zealand
5.4.8.1 New Zealand biopharma excipients market, by revenue 2017 – 2028 (USD Million)
5.4.9 Australia
5.4.9.1 Australia biopharma excipients market, by revenue 2017 – 2028 (USD Million)
5.4.10 Singapore
5.4.10.1 Singapore biopharma excipients market, by revenue 2017 – 2028 (USD Million)
5.4.11 Indonesia
5.4.11.1 Indonesia biopharma excipients market, by revenue 2017 – 2028 (USD Million)
5.5 Latin America
5.5.1 Latin America biopharmaceutical excipients market, 2017 – 2028 (USD Million)
5.5.2 Brazil
5.5.2.1 Brazil biopharmaceutical excipients market, 2017 – 2028 (USD Million)
5.6 Middle East & Africa (MEA)
5.6.1 Middle East & Africa biopharmaceutical excipients market, 2017 – 2028 (USD Million)
5.6.2 South Africa
5.6.2.1 South Africa biopharmaceutical excipients market, 2017 – 2028 (USD Million)
Chapter 6 Competitive Landscape
6.1 Strategy Framework
6.2 Market Participation Categorization
6.3 Company Profiles
6.3.1 Merck KGaA
6.3.1.1 Company overview
6.3.1.1.1 Merck Millipore
6.3.1.2 Financial performance
6.3.1.3 Product benchmarking
6.3.1.4 Strategic initiatives
6.3.2 Signet Chemical Corporation Pvt. Ltd.
6.3.2.1 Company overview
6.3.2.2 Financial performance
6.3.2.3 Product benchmarking
6.3.2.4 Strategic initiatives
6.3.3 Sigachi Industries Pvt. Ltd.
6.3.3.1 Company overview
6.3.3.2 Financial performance
6.3.3.3 Product benchmarking
6.3.3.4 Strategic initiatives
6.3.4 Associated British Foods
6.3.4.1 Company overview
6.3.4.2 ABITEC
6.3.4.2.1 Company overview
6.3.4.3 SPI Pharma
6.3.4.3.1 Company overview
6.3.4.4 Financial performance
6.3.4.4.1 Financial performance: ABITEC
6.3.4.4.1 Financial performance: SPI Pharma, Inc
6.3.4.5 Product benchmarking
6.3.4.6 Strategic initiatives
6.3.5 Spectrum Chemical Manufacturing Corp.
6.3.5.1 Company overview
6.3.5.2 Financial performance
6.3.5.3 Product benchmarking
6.3.5.4 Strategic initiatives
6.3.6 Roquette Frères
6.3.6.1 Company overview
6.3.6.2 Financial performance
6.3.6.3 Product benchmarking
6.3.6.4 Strategic initiatives
6.3.7 IMCD
6.3.7.1 Company overview
6.3.7.1.1 Indchem International
6.3.7.2 Financial performance
6.3.7.3 Product benchmarking
6.3.7.4 Strategic initiatives
6.3.8 Clariant
6.3.8.1 Company overview
6.3.8.2 Financial performance
6.3.8.3 Product benchmarking
6.3.8.4 Strategic initiatives
6.3.9 DFE Pharma
6.3.9.1 Company overview
6.3.9.2 Product benchmarking
6.3.9.3 Strategic initiatives
6.3.10 Colorcon
6.3.10.1 Company overview
6.3.10.2 Financial performance
6.3.10.3 Product benchmarking
6.3.10.4 Strategic initiatives
6.3.11 J. RETTENMAIER & SÖHNE GmbH + Co KG
6.3.11.1 Company overview
6.3.11.2 JRS PHARMA
6.3.11.3 Company overview
6.3.11.4 Financial performance
6.3.11.5 Product benchmarking
6.3.11.6 Strategic initiatives
6.3.12 BASF SE
6.3.12.1 Company overview
6.3.12.2 Financial performance
6.3.12.3 Product benchmarking
6.3.12.4 Strategic initiatives
6.3.13 Evonik Industries AG
6.3.13.1 Company overview
6.3.13.2 Financial performance
6.3.13.3 Product benchmarking
6.3.13.4 Strategic initiatives

List of Tables

TABLE 1 Primary interview details: North America
TABLE 2 Primary interview details: Europe
TABLE 3 Primary interview details: APAC
TABLE 4 Primary interview details: Latin America
TABLE 5 Primary interview details: MEA
TABLE 6 List of secondary sources
TABLE 7 List of top 10 drugs in 2020 by sales
TABLE 8 Chemically reactive oxidation products formed by use of Polysorbate 80
TABLE 9 The frequency of inclusion of polyols in mAb formulations (%)
TABLE 10 North America biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 11 North America biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (Tonnes)
TABLE 12 North America solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 13 North America solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 14 North America polyol excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 15 North America polyol excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 16 North America carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 17 North America carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 18 U.S. biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 19 U.S. biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (Tonnes)
TABLE 20 U.S. solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 21 U.S. solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 22 U.S. polyol excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 23 U.S. polyol excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 24 U.S. carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 25 U.S. carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 26 Canada biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 27 Canada biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (Tonnes)
TABLE 28 Canada solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 29 Canada solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 30 Canada polyol excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
 TABLE 31 Canada polyol excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 32 Canada carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 33 Canada carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 34 Europe biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 35 Europe biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (Tonnes)
TABLE 36 Europe solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 37 Europe solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 38 Europe polyol excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 39 Europe polyol excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 40 Europe carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 41 Europe carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 42 Germany biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 43 Germany biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (Tonnes)
TABLE 44 Germany solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 45 Germany solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 46 Germany polyol excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 47 Germany polyol excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 48 Germany carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 49 Germany carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 50 U.K. biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 51 U.K. biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (Tonnes)
TABLE 52 U.K. solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 53 U.K. solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 54 U.K. polyol excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 55 U.K. polyol excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 56 U.K. carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 57 U.K. carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 58 Asia Pacific biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 59 Asia Pacific biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (Tonnes)
TABLE 60 Asia Pacific solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (USD Million)
 TABLE 61 Asia Pacific solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 62 Asia Pacific polyol excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 63 Asia Pacific polyol excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 64 Asia Pacific carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 65 Asia Pacific carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 66 Top selling biopharmaceuticals in Japan: 2020
TABLE 67 Japan biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 68 Japan biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (Tonnes)
TABLE 69 Japan solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 70 Japan solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 71 Japan polyol excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 72 Japan polyol excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 73 Japan carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 74 Japan carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 75 China biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 76 China biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (Tonnes)
TABLE 77 China solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 78 China solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 79 China polyol excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 80 China polyol excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 81 China carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 82 China carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 83 India biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 84 India biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (Tonnes)
TABLE 85 India solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 86 India solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 87 India polyol excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 88 India polyol excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 89 India carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 90 India carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 91 Malaysia: Approved biosimilars
TABLE 92 Malaysia biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 93 Malaysia biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (Tonnes)
TABLE 94 Malaysia solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 95 Malaysia solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 96 Malaysia polyol excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 97 Malaysia polyol excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 98 Malaysia carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 99 Malaysia carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 100 South Korea: Approved Biosimilars
TABLE 101 South Korea biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 102 South Korea biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (Tonnes)
TABLE 103 South Korea solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 104 South Korea solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 105 South Korea polyol excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 106 South Korea polyol excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 107 South Korea carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 108 South Korea carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 109 Philippines biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 110 Philippines biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (Tonnes)
TABLE 111 Philippines solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 112 Philippines solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 113 Philippines polyol excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 114 Philippines polyol excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 115 Philippines carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 116 Philippines carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 117 New Zealand biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 118 New Zealand biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (Tonnes)
TABLE 119 New Zealand solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (USD Million) 
TABLE 120 New Zealand solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 121 New Zealand polyol excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 122 New Zealand polyol excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 123 New Zealand carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 124 New Zealand carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 125 Australia biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 126 Australia biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (Tonnes)
TABLE 127 Australia solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 128 Australia solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 129 Australia polyol excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 130 Australia polyol excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 131 Australia carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 132 Australia carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 133 Singapore biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 134 Singapore biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (Tonnes)
TABLE 135 Singapore solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 136 Singapore solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 137 Singapore polyol excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 138 Singapore polyol excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 139 Singapore carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 140 Singapore carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 141 Indonesia biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 142 Indonesia biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (Tonnes)
TABLE 143 Indonesia solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 144 Indonesia solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 145 Indonesia polyol excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 146 Indonesia polyol excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 147 Indonesia carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million) 
TABLE 148 Indonesia carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 149 Latin America biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 150 Latin America biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (Tonnes)
TABLE 151 Latin America solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 152 Latin America solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 153 Latin America polyol excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 154 Latin America polyol excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 155 Latin America carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 156 Latin America carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 157 Brazil biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 158 Brazil biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (Tonnes)
TABLE 159 Brazil solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 160 Brazil solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 161 Brazil polyol excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 162 Brazil polyol excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 163 Brazil carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 164 Brazil carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 165 Middle East & Africa biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 166 Middle East & Africa biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (Tonnes)
TABLE 167 Middle East & Africa solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 168 Middle East & Africa solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 169 Middle East & Africa polyol excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 170 Middle East & Africa polyol excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 171 Middle East & Africa carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 172 Middle East & Africa carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 173 South Africa biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 174 South Africa biopharmaceutical excipients market estimates & forecasts, by product, 2017 - 2028 (Tonnes)
TABLE 175 South Africa solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 176 South Africa solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 177 South Africa polyol excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 178 South Africa polyol excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)
TABLE 179 South Africa carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 180 South Africa carbohydrate excipients market estimates & forecasts, by type, 2017 - 2028 (Tonnes)

List of Figures

FIG. 1 Market snapshot
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value chain - based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market formulation & validation
FIG. 9 Commodity flow analysis
FIG. 10 Volume price analysis
FIG. 11 Market trends & outlook
FIG. 12 Market segmentation & scope
FIG. 13 Market driver relevance analysis (Current & future impact)
FIG. 14 Market restraint relevance analysis (Current & future impact)
FIG. 15 Penetration & growth prospect mapping for products, 2020
FIG. 16 SWOT Analysis, By Factor (political & legal, economic, and technological)
FIG. 17 Porter’s Five Forces Analysis
FIG. 18 Global biopharma excipients market: Product outlook key takeaways
FIG. 19 Biopharma excipients market: Product movement analysis
FIG. 20 Global solubilizers & surfactants/emulsifiers market, by revenue 2017 - 2028 (USD Million)
FIG. 21 Global solubilizers & surfactants/emulsifiers market, by volume 2017 - 2028 (Tonnes)
FIG. 22 Global triglycerides market, by revenue 2017 - 2028 (USD Million)
FIG. 23 Global triglycerides market, by volume 2017 - 2028 (Tonnes)
FIG. 24 Global esters market, by revenue 2017 - 2028 (USD Million)
FIG. 25 Global esters market, by volume 2017 - 2028 (Tonnes)
FIG. 26 Global other solubilizers market, by revenue 2017 - 2028 (USD Million)
FIG. 27 Global other solubilizers market, by volume 2017 - 2028 (Tonnes)
FIG. 28 Global polyols market, by revenue 2017 - 2028 (USD Million)
FIG. 29 Global polyols market, by volume 2017 - 2028 (Tonnes)
FIG. 30 Global mannitol market, by revenue 2017 - 2028 (USD Million)
FIG. 31 Global mannitol market, by volume 2017 - 2028 (Tonnes)
FIG. 32 Global sorbitol market, by revenue 2017 - 2028 (USD Million)
FIG. 33 Global sorbitol market, 2017 - 2028 (Tonnes)
FIG. 34 Global other polyols market, by revenue 2017 - 2028 (USD Million)
FIG. 35 Global other polyols market, by volume 2017 - 2028 (Tonnes)
FIG. 36 Global carbohydrates market, by revenue 2017 - 2028 (USD Million)
FIG. 37 Global carbohydrates market, by volume 2017 - 2028 (Tonnes)
FIG. 38 Global dextrose market, by revenue 2017 - 2028 (USD Million)
FIG. 39 Global dextrose market, by volume 2017 - 2028 (Tonnes)
FIG. 40 Global sucrose market, by revenue 2017 - 2028 (USD Million)
FIG. 41 Global sucrose market, 2017 - 2028 (Tonnes)
FIG. 42 Global starch market, by revenue 2017 - 2028 (USD Million)
FIG. 43 Global starch market, by volume 2017 - 2028 (Tonnes)
FIG. 44 Global other carbohydrates market, by revenue 2017 - 2028 (USD Million)
FIG. 45 Global other carbohydrates market, by volume 2017 - 2028 (Tonnes)
FIG. 46 Global specialty excipients market, by revenue 2017 - 2028 (USD Million)
FIG. 47 Global specialty excipients market, by volume 2017 - 2028 (Tonnes)
FIG. 48 Regional market place: Key takeaway
FIG. 49 Biopharmaceutical excipients regional outlook, 2017 & 2028
FIG. 50 North America biopharmaceutical excipients market, 2017 - 2028 (USD Million)
FIG. 51 U.S. biopharmaceutical excipients market, 2017 - 2028 (USD Million)
FIG. 52 Canada biopharmaceutical excipients market, 2017 - 2028 (USD Million)
FIG. 53 Europe biopharmaceutical excipients market, 2017 - 2028 (USD Million)
FIG. 54 Germany biopharmaceutical excipients market, 2017 - 2028 (USD Million)
FIG. 55 U.K. biopharmaceutical excipients market, 2017 - 2028 (USD Million)
FIG. 56 Asia Pacific biopharma excipients market, by revenue 2017 - 2028 (USD Million)
FIG. 57 Japan biopharma excipients market, by revenue 2017 - 2028 (USD Million)
FIG. 58 China biopharma excipients market, by revenue 2017 - 2028 (USD Million)
FIG. 59 India biopharma excipients market, by revenue 2017 - 2028 (USD Million)
FIG. 60 Malaysia biopharma excipients market, by revenue 2017 - 2028 (USD Million)
FIG. 61 South Korea biopharma excipients market, by revenue 2017 - 2028 (USD Million)
FIG. 62 Philippines biopharma excipients market, by revenue 2017 - 2028 (USD Million)
FIG. 63 New Zealand biopharma excipients market, by revenue 2017 - 2028 (USD Million)
FIG. 64 Australia biopharma excipients market, by revenue 2017 - 2028 (USD Million)
FIG. 65 Singapore biopharma excipients market, by revenue 2017 - 2028 (USD Million)
FIG. 66 Indonesia biopharma excipients market, by revenue 2017 - 2028 (USD Million)
FIG. 67 Latin America biopharmaceutical excipients market, 2017 - 2028 (USD Million)
FIG. 68 Brazil biopharmaceutical excipients market, 2017 - 2028 (USD Million)
FIG. 69 Middle East & Africa biopharmaceutical excipients market, 2017 - 2028 (USD Million)
FIG. 70 South Africa biopharmaceutical excipients market, 2017 - 2028 (USD Million)
FIG. 71 Strategy framework
FIG. 72 Participant categorization

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界のバイオ医薬品添加剤市場2021-2028:製品別(ポリオール、可溶化剤・界面活性剤/乳化剤、炭水化物)、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆